Special Focuses

Special Focuses

  1. Promote Taiwan Consortium of Acute Kidney Injury and Renal Diseases (CAKs) as the leading kidney diseases of clinical trial group in Asia-Pacific by establishing a cohesive group of kidney clinical trial sites that conduct uniform standard-of-care and high quality clinical trial performance in renal diseases and provide credible and reliable data through ICH-GCP compliant clinical trials.
  2. Advance Taiwan to be one of the leading countries for the international kidney diseases clinical trials and new drug application and to attract international pharmaceutical companies to perform their kidney diseases clinical trials in Taiwan or perform their international clinical trials led by the principal investigators in Taiwan.

Share the clinical trials related data and research achievements, to promote the international research collaboration and to provide the members with the information and opportunities for participating in the international clinical trials.

圖片

圖片